Vascular responses to 8-nitro-cyclic GMP in non-diabetic and diabetic mice

British Journal of Pharmacology

Volumn 162, Issue 8, 2011, Pages 1884-1893

  Tokutomi, Yoshiko ^a,b   Kataoka, Keiichiro ^a   Yamamoto, Eiichiro ^a   Nakamura, Taishi ^a   Fukuda, Masaya ^a   Nako, Hisato ^a   Toyama, Kensuke ^a   Dong, Yi Fei ^a   Ahmed, Khandaker Ahtesham ^a   Sawa, Tomohiro ^a   Akaike, Takaaki ^a   Kim Mitsuyama, Shokei ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b Kumamoto University   (Japan)

Author keywords

8 nitro cGMP; aorta; db db mouse; eNOS; superoxide anions; vascular responses

Indexed keywords

8 BROMO CYCLIC GMP; 8 NITRO CYCLIC GMP; CYCLIC NUCLEOTIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DILATATION; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THORACIC AORTA;

ANIMALS; AORTA, THORACIC; BLOTTING, WESTERN; CYCLIC GMP; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE III; OBESITY; PHENYLEPHRINE; VASOCONSTRICTION; VASODILATION;

EID: 79953060812     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01201.x     Document Type: Article

References (22)

1. Baynes JW, Thorpe SR, (1999). Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48: 1-9. (Pubitemid 29019345)
2. Cai H, Harrison DG, (2000). Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840-844.
3. 1-adrenoceptors regulate neo-angiogenesis. Br J Pharmacol 153: 936-946.
4. DeRubertis FR, Craven PA, Melhem MF, Salah EM, (2004). Attenuation of renal injury in db/db mice overexpressing superoxide dismutase: evidence for reduced superoxide-nitric oxide interaction. Diabetes 53: 762-768. (Pubitemid 38270647)
5. Dong YF, Liu L, Kataoka K, Nakamura T, Fukuda M, Tokutomi Y, et al,. (2010). Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes. Diabetologia 53: 180-191.
6. Feil R, Lohmann SM, de Jonge H, Walter U, Hofmann F, (2003). Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice. Circ Res 93: 907-916. (Pubitemid 37433228)
7. Kaneko K, Sunano S, (1993). Involvement of alpha-adrenoceptors in the endothelium-dependent depression of noradrenaline-induced contraction in rat aorta. Eur J Pharmacol 240: 195-200. (Pubitemid 23255216)
8. Komas N, Lugnier C, Stoclet JC, (1991). Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors. Br J Pharmacol 104: 495-503.
9. Kukovetz WR, Holzmann S, Wurm A, Poch G, (1979). Evidence for cyclic GMP-mediated relaxant effects of nitro-compounds in coronary smooth muscle. Naunyn Schmiedebergs Arch Pharmacol 310: 129-138. (Pubitemid 10179566)
10. Lincoln TM, Cornwell TL, (1993). Intracellular cyclic GMP receptor proteins. FASEB J 7: 328-338. (Pubitemid 23067783)
11. McMahon TJ, Ignarro LJ, Kadowitz PJ, (1993). Influence of Zaprinast on vascular tone and vasodilator responses in the cat pulmonary vascular bed. J Appl Physiol 74: 1704-1711. (Pubitemid 23133463)
12. Mohazzab KM, Kaminski PM, Wolin MS, (1994). NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol 266: H2568-H2572. (Pubitemid 24215893)
13. Moien-Afshari F, Ghosh S, Elmi S, Rahman MM, Sallam N, Khazaei M, et al,. (2008). Exercise restores endothelial function independently of weight loss or hyperglycaemic status in db/db mice. Diabetologia 51: 1327-1337.
14. Nakamura T, Kataoka K, Fukuda M, Nako H, Tokutomi Y, Dong YF, et al,. (2009). Critical role of apoptosis signal-regulating kinase 1 in aldosterone/salt-induced cardiac inflammation and fibrosis. Hypertension 54: 544-551.
15. Pannirselvam M, Verma S, Anderson TJ, Triggle CR, (2002). Cellular basis of endothelial dysfunction in small mesenteric arteries from spontaneously diabetic (db/db -/-) mice: role of decreased tetrahydrobiopterin bioavailability. Br J Pharmacol 136: 255-263. (Pubitemid 34587672)
16. Pannirselvam M, Simon V, Verma S, Anderson T, Triggle CR, (2003). Chronic oral supplementation with sepiapterin prevents endothelial dysfunction and oxidative stress in small mesenteric arteries from diabetic (db/db) mice. Br J Pharmacol 140: 701-706. (Pubitemid 37386434)
17. Romero M, Jiménez R, Sánchez M, López- Sepúlveda R, Zarzuelo MJ, O'Valle F, et al,. (2009). Quercetin inhibits vascular superoxide production induced by endothelin-1: role of NADPH oxidase, uncoupled eNOS and PKC. Atherosclerosis 202: 58-67.
18. Sawa T, Akaike T, Ichimori K, Akuta T, Kaneko K, Nakayama H, et al,. (2003). Superoxide generation mediated by 8-nitroguanosine, a highly redox-active nucleic acid derivative. Biochem Biophys Res Commun 311: 300-306. (Pubitemid 37340076)
19. Sawa T, Zaki MH, Okamoto T, Akuta T, Tokutomi Y, Kim-Mitsuyama S, et al,. (2007). Protein S-guanylation by the biological signal 8-nitroguanosine 3′,5′-cyclic monophosphate. Nat Chem Biol 3: 727-735. (Pubitemid 47609113)
20. Vanhoutte PM, Shimokawa H, Tang EHC, Feletou M, (2009). Endothelial dysfunction and vascular disease. Acta Physiol 196: 193-222.
21. Yamamoto E, Kataoka K, Shintaku H, Yamashita T, Tokutomi Y, Dong YF, et al,. (2007a). Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure. Arterioscler Thromb Vasc Biol 27: 2569-2575. (Pubitemid 350158907)
22. Yamamoto E, Yamashita T, Tanaka T, Kataoka K, Tokutomi Y, Lai ZF, et al,. (2007b). Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt-sensitive hypertensive rats, via pleiotropic effects. Arterioscler Thromb Vasc Biol 27: 556-563.